Adverum Biotechnologies Stock Investor Sentiment
| ADVM Stock | USD 5.10 0.50 8.93% |
About 64% of all Adverum Biotechnologies' investors are looking to take a long position. The analysis of the overall investor sentiment regarding Adverum Biotechnologies suggests that some traders are interested. Adverum Biotechnologies' investing sentiment overview a quick insight into current market opportunities from investing in Adverum Biotechnologies. Many technical investors use Adverum Biotechnologies stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Adverum |
Adverum Biotechnologies Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Adverum Biotechnologies can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about Adverum Biotechnologies that are available to investors today. That information is available publicly through Adverum media outlets and privately through word of mouth or via Adverum internal channels. However, regardless of the origin, that massive amount of Adverum data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Adverum Biotechnologies news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Adverum Biotechnologies relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Adverum Biotechnologies' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Adverum Biotechnologies alpha.
Adverum Biotechnologies Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | ADVM stock touches 52-week low at 4.01 amid market challenges - MSN | 02/04/2025 |
2 | Adverum Biotechnologies Stock Crosses Below Two Hundred Day Moving Average - Whats Next - MarketBeat | 02/07/2025 |
3 | Acquisition by Svoronos Dawn of 40000 shares of Adverum Biotechnologies subject to Rule 16b-3 | 02/14/2025 |
4 | Acquisition by Rubinstein Linda M of 8125 shares of Adverum Biotechnologies subject to Rule 16b-3 | 02/25/2025 |
5 | Acquisition by Leonard Braden Michael of 164886 shares of Adverum Biotechnologies at 4.0087 subject to Rule 16b-3 | 02/26/2025 |
6 | Acquisition by Leonard Braden Michael of 86802 shares of Adverum Biotechnologies at 4.4595 subject to Rule 16b-3 | 02/27/2025 |
7 | Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635 | 02/28/2025 |
8 | Adverum Biotechnologies Inc expected to post a loss of 1.36 a share - Earnings Preview - TradingView | 03/14/2025 |
9 | Acquisition by Leonard Braden Michael of 18000 shares of Adverum Biotechnologies at 4.6 subject to Rule 16b-3 | 03/18/2025 |
10 | Acquisition by Leonard Braden Michael of 25000 shares of Adverum Biotechnologies at 4.9356 subject to Rule 16b-3 | 03/19/2025 |
11 | Acquisition by Leonard Braden Michael of 30600 shares of Adverum Biotechnologies at 5.6133 subject to Rule 16b-3 | 03/20/2025 |
12 | Acquisition by Laurent Fischer of 200000 shares of Adverum Biotechnologies at 7.15 subject to Rule 16b-3 | 03/21/2025 |
Check out Adverum Biotechnologies Hype Analysis, Adverum Biotechnologies Correlation and Adverum Biotechnologies Performance. To learn how to invest in Adverum Stock, please use our How to Invest in Adverum Biotechnologies guide.You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adverum Biotechnologies. If investors know Adverum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adverum Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.95) | Revenue Per Share | Quarterly Revenue Growth (0.70) | Return On Assets | Return On Equity |
The market value of Adverum Biotechnologies is measured differently than its book value, which is the value of Adverum that is recorded on the company's balance sheet. Investors also form their own opinion of Adverum Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Adverum Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adverum Biotechnologies' market value can be influenced by many factors that don't directly affect Adverum Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adverum Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Adverum Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adverum Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.